Effects of Boswellia species on viral infections with particular attention to SARS-CoV-2.

Jamshidi, Zahra; Hashemi, Maryam; Yazdian-Robati, Rezvan; Etemad, Leila; Salmasi, Zahra; Kesharwani, Prashant

Jamshidi, Zahra; Hashemi, Maryam; Yazdian-Robati, Rezvan; Etemad, Leila; Salmasi, Zahra; Kesharwani, Prashant.

Afiliación

Jamshidi Z; Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
Hashemi M; Department of Medicinal Chemistry, Mashhad University of Medical Sciences, Mashhad, Iran.
Yazdian-Robati R; Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
Etemad L; Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
Salmasi Z; Molecular and Cell Biology Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Kesharwani P; Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.

Inflammopharmacology ; 30(5): 1541-1553, 2022 Oct.

Article en En | MEDLINE | ID: mdl-35882701

Asunto(s)

Boswellia; Tratamiento Farmacológico de COVID-19; Antivirales/farmacología; Antivirales/uso terapéutico; Humanos; Pandemias; SARS-CoV-2

Palabras clave

Antiviral effect; Boswellia species; Herbal medicine; Natural therapies; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Boswellia / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Revista: Inflammopharmacology Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article País de afiliación: Irán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google